Swedish infants were vaccinated with diphtheria, tetanus and pertussis toxo
ids, inactivated poliovirus vaccine and a Haemophilus influenzae type b - t
etanus toroid conjugate vaccine at 2, 4, 6 and 15 months (US vaccination pr
ogram, IUS arm', n = 118) or at 3, 5 and 12 months of age (Swedish vaccinat
ion program,'Swedish arm', n = 103). The antigen amounts in the diphtheria
and tetanus vaccines were higher in the Swedish than in the US arm while th
e amounts in the other vaccines were the same in both arms. There were no s
erious side effects. Local reactions increased with the numbers of doses bu
t did not differ significantly between the groups. Serum was obtained at 2.
7, 15 and 16 months in the US arm and at 3, 6, 12 and 13 months of age in
the Swedish arm. A fifth serum was obtained in both groups at 4 yr of age.
For vaccines with the same antigen amount the following was observed: a. th
ree doses at 2? 4 and 6 months were more immunogenic than two doses at 3 an
d 5 months; b. the third dose in the Swedish arm was more immunogenic than
the third dose in the US arm; c, the fourth dose in the US arm induced high
er antibodies than the third dose in the Swedish arm (except for pertussis
toxin antibodies that were similar in both groups) and the differences tend
ed to remain at the age of 4 yr. Children in the Swedish arm received a hig
her diphtheria toroid dose (25 Lf) than in the US arm (15 Lf) which led to
higher diphtheria toxin antibodies in the Swedish arm at comparable ages. C
hildren in the Swedish arm received a higher tetanus toroid dose (7 Lf) tha
n in the US arm (6 Lf). Tetanus antibodies were similar at comparable ages.
In conclusion, the immunogenicity of vaccines in infancy can be improved b
y increasing the number of doses, by prolonging the intervals between doses
and by increasing the antigen amount in the vaccine. (C) 1999 Elsevier Sci
ence Ltd. All rights reserved.